News from collegium pharmaceutical, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 31, 2013, 08:00 ET

Collegium Pharmaceutical's CEO to Present at the Jefferies 2013 Global Health Care Conference in New York on June 4, 2013

 Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that the Company's President and CEO, Michael Heffernan,...

May 17, 2013, 07:30 ET

Collegium Pharmaceutical's CEO to Present at the UBS Global Health Care Conference in New York on May 20, 2013

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that the Company's President and CEO, Michael Heffernan, will...

May 08, 2013, 08:00 ET

Collegium Announces Poster Presentation for Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid at American Pain Society's 32nd Annual Scientific Meeting

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today...

Apr 30, 2013, 07:00 ET

Collegium Announces Results of Chronic Pain Patient Survey - Confirms Significant Unmet Medical Need for a Differentiated, Abuse-Deterrent, Extended-Release Opioid

 Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today...

Apr 22, 2013, 07:00 ET

Significant Unmet Medical Need for Treatment of Patients with Chronic Pain with Dysphagia (CPD)

 Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today...

Apr 17, 2013, 07:00 ET

Collegium Pharmaceutical Announces Successful Completion of Clinical Study Evaluating the Impact of Tampering on Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid Product

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today...

Apr 03, 2013, 07:00 ET

Collegium Pharmaceutical Names Douglas Carlson to Vice President of Business Development

 Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, has...

Feb 28, 2013, 07:00 ET

Collegium Pharmaceutical's CEO to Present at the Cowen & Company 33rd Annual Health Care Conference in Boston on March 6, 2013

 Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that the company's President and CEO, Michael Heffernan,...

Feb 12, 2013, 07:00 ET

Collegium Pharmaceutical Inc. Announces Notice of Allowance for U.S. Patent Covering Oxycodone DETERx®, a Tamper-Resistant, Extended-Release Opioid Product

 Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that it has received Notice of Allowance from the U.S....

Jan 17, 2013, 07:00 ET

Collegium Pharmaceutical Announces Relocation to Massachusetts

 Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today...

Nov 27, 2012, 07:00 ET

Collegium Pharmaceutical to Present at Piper Jaffray's 24th Annual Healthcare Conference

 Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic...

Oct 19, 2012, 07:00 ET

Collegium Announces Poster Presentation for Oxycodone DETERx®, a Tamper-Resistant, Extended-Release Opioid at 2012 American Association of Pharmaceutical Scientists Annual Meeting

 Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today...